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A polypeptide of 224 amino acids from the C terminus of rat thyroglobalin fused to Staphylococcal protein A (TgC 224). containing 3 tyrosines 
which have been shown to be hormonogenic in vivo (Tyr-2555, -2569 and .2748), forms thyroid hormones wlth relatively high efficiency upon in 
vitro enzymatic odination using, most likely, the hormonogenic Tyr-2555 and Tyr-2569. Acetylcholinesterase, which has sequence and structural 
homology with the C terminus of the thyroglobulin molecule and bovine serum albumin, used as control proteins, formed thyroid hormones with 
lower efficiency, These results validate our experimental pproach to define the structural requirements for thyroid hormone formatior, using 
thyroglobulin fragments, 
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1. INTRODUCTION 
The size or thyroglobulin represents a serious hand- 
icap for understanding the mechanism of biosynthesis 
of thyroid hormones by conventional techniques. 
Recently, thanks to the availability of recombinant 
DNA technology, the primary sequence of Tg from 
various species has been determined [1-3]. It became 
apparent that the structure of Tg has been well 
preserved uring evolution in vertebrates, uggesting 
that it is well fitted for an efficient hyroid hormono- 
genesis, as shown earlier from in vitro iodination studies 
[4-6]. Still, the size of the Tg molecule seems to be out 
of proportion with the relatively very low yield of 
hormones (3-4 residues/molecule) r stricted mainly to 
4 hormonogenie sites [7-9] located in both the amino 
and the carboxy terminus, though an additional site has 
been recently reported in the middle of the molecule 
[10]. 
The presence of small, abnormal, Tg antigens in the 
hereditary goitre of the Afrikander cattle [i 1] and the 
Dutch goat [12], containing the N-terminal hormono- 
genie site could be responsible for the euthyroid state of 
the former and also for the correction by'iodide ad- 
ministration of the hypothyroidism of the latter 
goitrous animals. This probably indicates that this site, 
which plays a very important functional role in the full- 
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size Tg molecule [13] is also very important in the ab- 
normal Tg [14]. It could eventually serve as a functional 
hormone precursor even out of the context of the entire 
Tg molecule as it has been suggested on the basis of the 
absence of sequence homology among different hormo- 
nogenic sites [15]. This evidence was taken as an indica- 
tion that the different sites evolved independently and, 
consequently, that they could also function independ- 
ently from each other. Thus, although the size of the Tg 
molecule could have evolved for an efficient synthesis 
of thyroid hormones and the storage in non-discharge- 
able form of iodine which is scarce in the earth's crust 
[6], it is also possible that the whole molecule is not 
directly involved in thyroid hormone biosynthesis. In 
order to investigate this possibility and also to define the 
structural requirements of the Tg molecule, we have 
synthesized [16] a construct of 224 amino acids from the 
C-terminal end of rat Tg (TgC 224) comparing its ef- 
ficiency of thyroid hormone formation upon in vitro 
iodination with that of iodine poor human Tg, 
acetyleholinesterase (ACHE), which has sequence and 
structural homology with the C-terminal end of Tg but 
lacks its hormonogenic Tyr residues [17], and bovine 
serum albumin (BSA). 
2. MATERIALS AND METHODS 
2,1, Pla~'tnids 
A thyroglobulin eDNA fragment, encoding for the last 224 amino 
acids at the carboxy terminus (position 2232-3018 in the sequence in 
get'. [31) and containing the 3' untranslated region, was excised from 
plasmid pRT57 (3) with EcoRI and Pstl and cloned in the correspond- 
ing sites in the vector pERAT 316. In the resulting construct (pUM3) 
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the thyroglobnlin coding sequence is fused, in frame, with the region 
coding for Staphylococcal protein A. pUre3 was introduced into E. 
coil RR 1 harbouring the low copy plasmid pNF2690 and the synthesis 
of the hybrid protein (TgC 224) was induced as described [18], 
2,2, Proteins 
Thyroglobulin, Iodine poor human Tg (660 kDa, 0,01% I; < I atom 
l/molecule) was purified and lyophilized as previously described [19], 
For numbering the Tyr residues in TgC 224 we have followed the same 
as in reference [I] for bovine Tg, 
Acetylcholinesterase (ACHE. 300 kDa) from electric eel and bovine 
serum albumin (BSA, 60 kDa) were from Sigma, 
TgC 224, Extracts from induced bacterial cultures harbouring the 
pUM3 plasmid were prepared by sonication in a buffer containing 50 
mM Tris-HCl pH 7,5, 100 mM NaCI, I mM EDTA, 0.5 mM PMSF 
(buffer A), The cell extract was centrifuged, the supernatant was made 
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Fig. 1, Panel A, the structure of the pUM3 plasmid is shown. Empty 
box, NH~ terminus ofcro; stippled box, protein A coding region; black 
box, Tg coding region; lightly stippled box, Tg 3' untranslated region. 
Panel B, SDS-PAGE stained with Coomassie blue of crude extracts 
from uninduced (U) or induced (I) E, coti RRi containing the pUMS 
plasmid and the purified TgC 224 protein (P). Arrowheads indicate 
induced proteins. The position of TgC 224 and of molecular weight 
markers is indicated. 
dialyzed a~ainst buffer A. Purification of the hybrid protein was 
achieved by affinity chromatography. CNBr activated Sepharose-4B 
(Pharmacla) was coupled to rabbit anti-Tg Ig-G according to the 
manufacturer's in tructions, The dialyzed bacterial extract was cycled 
on the column three times. The column was washed sequentially with 
buffer A. Each wash was carried out until the A,.~ of effluent was 
<0,01, The bound proteins were then eluted with 0.5 M arctic acid and 
adjusted to pH 3.5 with ammonium acetate. The protein peak was 
pooled, dialyzed against 50 mM Tris-HCI pH 7.5 and stored at -20"C. 
2.3. Enzymatic iodination 
The various proteins were iodinated in vitro using lactoperoxidas¢ 
and glucose-glucose ozidase as previously described [19], The io- 
dinated proteins were separated from the excess iodide and reagents 
by filtration through ECONOPAC 10 DG (Bio-Rad) disposable 
columns in 0,01 M Tris.HCl, 0.001 M MMI0 pH 8.5. 
2.4, Reduction, alkylutton and trypsln digestion 
The iodinated TgC 224 was reduced, alkylated and digested with 
TPCK trypsin (Sigma, 5% w/w) in 1% ammonium bicarbonate. 0.01% 
SDS for 16 h at 37°C, stopping the reaction with trifluoroacctle acid 
(TFA, Merck) and lyophylization as previously described [20], 
2,5, HPLC fractionation of tryptic digests and sequencing of purified 
peptides 
The tryptic peptides from iodinated Tee 224 were fractionateA by 
HPLC on a Ultrapack'rM Octyl C~ reverse-phase column (Beckman). 
The column was run at 0,5 ml/rnin and was initially equilibrated with 
95% phase A (0,7% ammonium bicarbonate containing 5% aceto- 
nitrile) 5% phase B (100% acetonitril¢) at room temperature; eluted 
over 130 rain with a linear gradient of 5 to 40% phase B, then over 
10 rain to 100% phase B. They were further purified using a TFA- 
acetonitrile gradient. The column was equilibrated with 80% phase A 
(water, 0.09% TFA, pH 2.0), 20% phase B (water. 90% aeetonitrile. 
0,09% TFA) and eluted over 15 rain with 20% phase B° then over 275 
rain from 20 to 45% phase B and then over 30 rain from 45 to 100% 
phase B. The column was monitored with a photodiode array detector 
and a NEC APC IV computer, by counting for t~Sl and by distribution 
of ~"51 among iodoamino adds after pronase digestion and paper 
chromatography of most HPLC fractions (0,5 ml fractions) as previ- 
ously described [201. The purified peptides were sequenced either in 
a Beckman or in a Knauer modular liquid-phase protein S~lUgnegr 
equipped on line with a Knauer phenyl thiohydantoin-amino acid 
analyzer, The laTH derivatives were identified and quantified on a 
reverse phase HPLC system based upon a Ct, column and gradient 
elution with 85% 6,5 mM sodium acetate, 15% acetonitrile, adjusted 
to pH 4.77 and 100% acetonitrile. Sequences were performed in the 
presence of polybreh:. An aliquot from the PTH-derivatives obtained 
in each ..,eXluence ycle were counted for t-~l. 
3, RESULTS 
The plasmid pUM3 (Fig. IA) allows the synthesis, in 
£. coli, of a rat thyroglobulin segment fused to Staphy- 
lococcal protein A (TgC 224). The hybrid protein shows 
the expected molecular weight (56 kDa) and can be 
readily purified on an anti-Tg antibody-Sepharose 4B 
column (Fig. 1B). TgC 224 accumulates in the over- 
producing strain as a partially soluble protein, as it 
distributes in almost equal parts between pellet and su- 
pernatant (data not shown). Only the soluble fraction 
was used in this study, to avoid the use of  denaturing 
agents which would be necessary to solubilize the preei- 
prated fraction. The bands of lower molecular weight, 
present in our purified preparations (Fig. I B), pre- 
sumably represent degradation products, as they are 
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Table 1 
Degree of iodination, ['"~l]iodoamino-aeid distribution a d number of residues tbrmed per molecule by in vitro enzymatic iodination ofiodin~ poor 
(0,01%) thyroglobulin, TgC 224, acelyleholinesterase and BSA (for more details ee text) 
Protein Atoms I / too l  ['-'Sl]iodoamino.acid distribution Residues/tool 
(%DIT) (%MIT) (%T4) (%T3) DIT MIT T4 T3 
Tg 17.5 34.5 31.1 19.5 1.5 3,1 5,4 0.85 0.09 
TgC 224 17.8 37,3 28,4 8,5 1.0 3,3 5,0 0.38 0.06 
ACHE 22.8 32.0 30,4 3,9 0.6 3,6 6,9 0.22 0.04 
BSA 17.0 52,5 17.8 5.6 0.4 4.4 3,0 0.27 0.02 
able to bind anti-Tg antibodies (data not shown), The 
contaminant of higher molecular weight, the nature of 
which is unknown, represented less than 10% of the 
total protein, To assess the efficiency of thyroid 
hormone formation in TgC 224, we compared it with a 
full-size human thyroglobulin, with ACHE, and with 
BSA. Table I shows that although Tg is the most effi- 
cient for thyroid hormone formation, TgC 224 is not 
only quite efficient but somewhat specific since it forms 
more than twice as much T4 than ACHE and almost 
twice as much as BSA, as more clearly summarized in
Fig. 2. 
In order to assess where the T4 formed by TgC 224 
was located, and to find out whether it is formed pre- 
ferentially at the same Tyr residues which have been 
demonstrated to be hormonogenic in vivo, the iodina- 
tion reaction was sealed up. 7 mg of TgC 224 was io. 
dinated in vitro with 1.25 x 10 -4 M potassium iodide 
labeled with radioiodide (S.A. = 1 ~tCi//~atom) ata level 
of 6.5 atoms of iodine per molecule. The iodoamino acid 
distribution of the iodinated protein was: 31.6% diiodo- 
tyrosine (DIT), 58.1% monoiodotyrosine (MIT), 3.5% 
T 4 and 2,7% triiodothyronine (T~), The tryptic peptides 
from iodinated TgC 224 were separated by successive 
HPLC gradients. Fig. 3 shows the ~:~I profile of the 
TFA gradient in the left panel and the t:~I cpm found 
as Z 4 in each fraction in the right panel, The T4-rich 
peaks numbered 1-6, contributing to as much as 57.5% 
of the total T4 formed, though also containing a high 
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Fit]. 2, Coupling efficiency corresponding to the data in Table I, 
measured asthe number of T.~ residues formed per atom of iodine 
bound per molecule ofTg, TgC 224, ACHE and BSA, 
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quencing, As shown in Table II, four of them (36.7% of 
the T4 formed by TgC 224) gave the same main and 
contaminating sequence corresponding toTg hormono- 
genie sites at Tyr-2555 and Tyr-2569, respectively 
[21,22]. The PTH derivatives were counted for ~2sI (data 
not shown) and though peaks were seen in position 18 
and 2, corresponding to the hormonogenic Tyrs in- 
cluded in the main and the contaminating sequence 
positions (positions 2555 and 2569, respectively), there 
was a higher peak in position 8 and 9, corresponding, 
most likely, to the iodotyrosines present in the peptides. 
4. DISCUSSION 
Although the primary sequence of the Tg molecule 
from various species has recently been made available 
[!-3], little progress has been made toward an under- 
standing of the process leading to the formation of 
thyroid hormones. In particular, no indication has been 
obtained on two key aspects of the hormonogenic 
process, i.e. the selection of some specific tyrosines and 
the requirements of the different parts of the molecule 
for an efficient utilization of iodine. 
Our approach to elucidate the molecular basis of the 
selection of a specific set of tyrosines for thyroid hor- 
mone formation has been to synthesize defined seg- 
ments of the Tg molecule containing hormonogenic 
sites [16] and to study their efficiency of thyroid hor- 
mone formation in vitro. If the same tyrosines are used 
in our simple model system as in vivo, then a mutagenic 
analysis could be undertaken to understand the struc- 
tural requirements for this highly specific process. We 
have obtained a 224 amino acid rat Tg fragment fused 
to Staphylococcal protein A (TgC 224). This segment of 
Tg contains a cluster of tyrosines among which three 
(Tyr-2555, -2569 and -2748) have been shown to be 
hormonogenic in vivo and in vitro [21,22]. To validate 
our construct we compared its ability to form thyroid 
hormones in vitro with that of the full-size Tg molecule. 
Two negative controls were used: (i) ACHE,  which 
shows a strong sequence homology with the C-terminal 
end of Tg tilthough it lacks the hormonogenic Tyr resi- 
dues [17]; (ii) BSA, because it is known that albumin, 
in the absence of the normal substrate Tg, as is the case 
of some congenital goitres [14], becomes iodinated and 
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Fig. 3. HPLC fractionation of tryptic peptides from in vitro iodinated, redueed-alkylated TgC 224. Left panel, total t-'~l cpm per fraction. Right 
panel, percent of the total T4 formed by TgC 224 found in the various fractions. The figures within the arrows indicate the percent of total T4 found 
among those fractions. Numbers by the sides of the peaks indicate those that were submitted to sequencing. For more details ¢¢ text. 
forms some thyroid hormones. The fact that TgC 224, 
which is less than 10% the size of Tg, forms, for com- 
parable degrees of iodination, almost half as much thy- 
roid hormone as Tg suggests that TgC 224 is quite 
efficient especially when considering that BSA formed 
about half as much and ACHE less than half. It was 
then very crucial to determine whether the T4 formed by 
TgC 224 was located within the Tg or the protein A 
portion. All The T4-rich peptides equenced not only 
belonged to the Tg portion but they were contained 
within Tg hormonogenic sites. Though not directly 
demonstrated, due to the scarcity of material, they most 
likely correspond to the hormonogenic Tyr-2555 and 
Tyr-2569. This essential point and the subsequent muta- 
genie study are under progress in a similar construct 
(TgC) which does not have the protein A portion and 
synthesizes thyroid hormones with similar efficiency as 
TgC 224 [23]. Recently Rawitch et al. [24] have reported 
a pulse-chase tudy with human Tg in which Tyr-5 was 
found to behave as the main hormonogenie site while 
Tyr-2555 behaved as a donor since the label found on 
it with the pulse was disappearing during the chase. 
Since the experimental conditions differ significantly it 
is difficult o interpret this difference at the moment. 
The present results how that a small Tg fragment, 
fused to Staphylococcal protein A produced in E. coli, 
forms a fair amount of thyroid hormone, in vitro, most 
likely using the Tg hormonogenic Tyr-2555 and -2569 
and indicate that the approach illustrated in this paper 
may give important information on the structural re- 
quirements for hormonogenesis in the Tg molecule. 
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